The novel therapy of this peptide represents a significant advance in the handling of the condition. Distinct from existing medications, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatide-peptide948461.p2blogs.com/40342327/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment